BOM/532331 (BOM/532331)

Bombay Stock Exchange: BOM/532331 · INR

₹3,452

+103.10 (+3.1%)· Recorded snapshot

Market cap	432.3B
Revenue (ttm)	57.8B
Net income (ttm)	11.3B
EPS (ttm)	₹90.8
P/E (trailing)	38.0x
P/E (forward)	33.1x
Dividend	₹60.0 (1.74%)
Volume	1,849

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 57.8B
Net income (ttm): 11.3B
EPS (ttm): ₹90.8
P/E (trailing): 38.0x
P/E (forward): 33.1x
Market cap: 432.3B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E33.1

P25 n/aP50 n/aP75 n/a

Trailing P/E38

P25 n/aP50 n/aP75 n/a

ROE25.4

P25 n/aP50 n/aP75 n/a

ROIC25.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BOM/532331 indicators

Market & fundamental data

Available fields

250

Groups with data

Currency

INR

Showing 250 of 250 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	INR
Country	India
Country code	IN
Earnings date	2026-10-30
Employees	10,421
Employees change	793
Employees growth	8.24%
Enterprise value	INR 428.3B
Exchange	Bombay Stock Exchange
Financial currency	INR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	March
Founded	1973
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	INE031B01049
Last earnings date	2026-07-30
Last refreshed	2026-10-28
Last stock split date	2022-06-22
Last stock split type	Forward
Market cap	INR 432.3B
Next earnings date	2026-10-30
Price	INR 3,451.70
Price currency	INR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	bom/532331
Website	https://www.ajantapharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	38.02x
Average P/E ratio (10Y)	28.46x
Average P/E ratio (3Y)	35.86x
Average P/E ratio (5Y)	31.73x
Earnings yield	2.63%
EV/Earnings	37.74x
EV/EBIT	30.57x
EV/EBITDA	27.18x
EV/FCF	261.1x
EV/Sales	7.41x
FCF / EV yield	0.38%
FCF yield	0.38%
Forward P/E	33.09x
Graham number	858.56178
Graham upside	-75.13%
Industry forward P/E	33.08x
Industry P/E	38.9x
Lynch fair value	INR 977.97
Lynch upside	-71.67%
P/(FCF - SBC) ratio	266x
P/(OCF - SBC) ratio	81.92x
P/B ratio	9.55x
P/E ratio	38.01x
P/FCF ratio	263.52x
P/OCF ratio	81.68x
P/S ratio	7.48x
Price / tangible book value	9.64x
Price/EBITDA ratio	27.64x
Sector forward P/E	36.12x
Sector P/E	45.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	24.26%
EBITDA margin	27.07%
Effective tax rate	24%
FCF margin	3.01%
Gross margin	77.22%
Operating margin	24.26%
Pretax margin	25.85%
Profit margin	19.65%
Profit per employee	INR 1.1M
Profitable quarters	49
Profitable years	22
Revenue per employee	INR 5.5M
ROA	14.85%
ROA (5Y)	13.22%
ROCE	27.99%
ROE	25.39%
ROE (5Y)	22.87%
ROIC	25.78%
ROIC (5Y)	24.72%
SBC / revenue	0.03%
Tax / revenue	6.21%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	22.02%
EPS growth (Q)	30.79%
EPS growth (QoQ)	25.21%
EPS growth 10Y	10.67%
EPS growth 3Y	23.07%
EPS growth 5Y	11.73%
EPS growth quarters	13
EPS growth years	3
FCF growth	-80.46%
FCF growth 3Y	-35.72%
FCF growth 5Y	-16.52%
Gross profit growth	22.03%
Gross profit growth (Q)	26.43%
Gross profit growth 3Y	17.76%
Gross profit growth 5Y	14.49%
Net income growth	22.04%
Net income growth (Q)	30.89%
Net income growth (QoQ)	25.32%
Net income growth 3Y	22.23%
Net income growth 5Y	10.79%
Net income growth quarters	13
Net income growth years	3
OCF growth	-54.27%
OCF growth 10Y	4.96%
OCF growth 3Y	-12.58%
OCF growth 5Y	-1.69%
Operating income growth	20.03%
Operating income growth (Q)	22.21%
Operating income growth 3Y	24.99%
Operating income growth 5Y	9.78%
Revenue growth	20.19%
Revenue growth (Q)	24.82%
Revenue growth (QoQ)	14.37%
Revenue growth 10Y	12.32%
Revenue growth 3Y	14.85%
Revenue growth 5Y	14.23%
Revenue growth quarters	29
Revenue growth years	7

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	INR -3.7B
Depreciation and amortization	INR 1.6B
EBIT	INR 14B
EBITDA	INR 15.6B
EPS	INR 90.81
Financing cash flow	INR -1.7B
Free cash flow	INR 1.6B
Free cash flow minus SBC	INR 1.6B
Gross profit	INR 44.6B
Income taxes	INR 3.6B
Investing cash flow	INR -4.3B
Net borrowing	INR 2B
Net cash flow	INR -676.5M
Net income	INR 11.3B
Operating cash flow minus SBC	INR 5.3B
Operating income	INR 14B
Revenue	INR 57.8B
Stock-based compensation	INR 15.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	INR 362.35
Debt / EBITDA	0.17
Debt / equity	0.06
Debt / FCF	1.62
Interest coverage	99.86
Net cash (debt)	INR 4B
Net cash / market cap	0.92%
Net cash growth	-29.44%
Net debt / EBITDA	-0.25
Net debt / equity	-0.09
Net debt / FCF	-2.42
Piotroski F-Score	5
Shareholders' equity	INR 45.3B
Tangible book value	INR 44.9B
Tangible book value per share	INR 359.03
Total cash	INR 6.6B
Total debt	INR 2.7B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.98
Current ratio	2.64
Inventory turnover	1.37
Quick ratio	1.88
Working capital	INR 23.2B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.01%
Dividend growth	0%
Dividend growth (10Y)	20.45%
Dividend growth (3Y)	23.31%
Dividend growth (5Y)	56.78%
Dividend growth years	0
Dividend payment date	2026-08-29
Dividend payment years	21
Dividend payout frequency	Annual
Dividend per share	INR 60.00
Dividend yield	1.74%
Ex-dividend date	2026-08-05
Last dividend	INR 32.00
Payout ratio	66.07%
Shareholder yield	1.73%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	155.3%
10Y return CAGR	10.94%
10Y total return	182.31%
150-day SMA	INR 3,251.11
15Y price change	11,575.73%
15Y return CAGR	38.57%
15Y total return	13,239.25%
1D price change	3.08%
1M price change	-5.64%
1M total return	-5.64%
1W price change	2.75%
1W total return	2.75%
1Y price change	38.75%
1Y return CAGR	41.63%
1Y total return	41.59%
20-day SMA	INR 3,417.92
200-day SMA	INR 3,155.98
20Y price change	49,931.38%
20Y return CAGR	38.14%
20Y total return	63,968.68%
3M price change	-0.53%
3M total return	0.38%
3Y price change	97.18%
3Y return CAGR	27.11%
3Y total return	105.41%
50-day SMA	INR 3,505.98
50-day SMA vs 200-day SMA	50over200
52-week high	INR 3,796.95
52-week high date	2026-08-18
52-week low	INR 2,381.50
52-week low date	2025-10-28
5Y price change	137.23%
5Y return CAGR	20.43%
5Y total return	153.28%
6M price change	21.01%
6M total return	22.12%
All-time high	INR 3,796.95
All-time high date	2026-08-18
All-time low	INR 1.88
All-time low date	2003-04-01
Average true range (ATR)	INR 109.07
Average volume	7K
Change from 52-week high	-9.09%
Change from 52-week low	44.94%
Change from all-time high	-11.81%
Change from all-time low	178,017.02%
Change from open	2.09%
Day's gap	0.97%
Dollar volume	INR 6.4M
High price	INR 3,470.00
Low price	INR 3,351.00
Monthly RSI	63.26
Open price	INR 3,380.95
Position in 52-week range	84.62%
Previous close	INR 3,348.60
Price vs 150-day SMA	3%
Price vs 20-day SMA	-2.03%
Price vs 200-day SMA	6.1%
Price vs 50-day SMA	-4.49%
Relative volume	0.27
RSI	44.43
Sharpe ratio	1.27
Sharpe ratio (3Y)	0.77
Sharpe ratio (5Y)	0.63
Sortino ratio	2.32
Sortino ratio (3Y)	1.42
Sortino ratio (5Y)	1.19
Volume	1.8K
Weekly RSI	52.85
YTD price change	20.88%
YTD total return	21.99%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	42M
Shares change (QoQ)	0.08%
Shares change (YoY)	0.01%
Shares held by insiders	42.19%
Shares held by institutions	22.25%

Deeper analysis on BOM/532331

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BOM/532331 report

Is a complete BOM/532331 research report available?

No complete published report is available for bom/532331 (BOM/532331) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BOM/532331 (BOM/532331)

Price

Financial snapshot

Fair-value bridge

Latest news · BOM/532331

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BOM/532331 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BOM/532331

Frequently asked questions